-
Divurgent and Gevity Announce Strategic Business Alliance
Post on 1/8/19
-
Ascentage Pharma Announces New License with Unity Biotechnology
Post on 1/8/19
-
Beam-Signing and Topping Out Ceremony for AAMC’s New Mental Health Hospital
Post on 1/7/19
-
RegeneRx Update on Dry Eye and EB Clinical Trials
Post on 1/4/19
-
Regenxbio: Is This The Best Performing Stock For 2019?
Post on 1/4/19
-
REGENXBIO Reports Continued Progress Across Programs in Year-End 2018 Corporate Update
Post on 1/3/19
-
VenatoRx Pharmaceuticals Joins Antimicrobials Working Group
Post on 1/3/19
-
Horizon Pharma plc and HemoShear Therapeutics Enter into Exclusive Drug Discovery Collaboration in Gout
Post on 1/3/19
-
Omega Healthcare Investors To Acquire MedEquities Realty Trust
Post on 1/2/19
-
Altria Makes $12.8 Billion Minority Investment in JUUL
Post on 12/20/18
-
Altimmune Reports Mixed Bag Of Updates
Post on 12/18/18
-
Emergent BioSolutions Receives Health Canada Approval of BioThrax
Post on 12/17/18
-
AbleVets Is a 2018 Best Workplace for Commuters in Fairfax County
Post on 12/17/18
-
Precision Medicine Group Acquires Stern Investor Relations
Post on 12/17/18
-
NW Bio Announces That UK Property Transaction Has Closed
Post on 12/14/18
-
NW Bio Announces That UK Property Transaction Has Closed
Post on 12/14/18
-
Why Ciena Stock Jumped Thursday
Post on 12/13/18
-
Ciena Corporation (CIEN) Q4 2018 Earnings Conference Call Transcript
Post on 12/13/18
-
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
Post on 12/13/18
-
VLP Therapeutics Awarded $3.9 million Grant by Global Health Innovative Technology Fund
Post on 12/12/18
-
Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University
Post on 12/12/18
-
Orgenesis Announces Collaboration with Ben-Gurion University
Post on 12/12/18
-
MacKenzie Contracting Completes ChoiceOne Urgent Care Center
Post on 12/11/18
-
Histo-Scientific Research Laboratories and Vet Path Services Merge
Post on 12/11/18
-
NW Bio Announces Non-Dilutive Funding of Approximately $47.3 Million Through UK Property Transaction
Post on 12/11/18